Log in

NASDAQ:DAREDare Bioscience Stock Price, Forecast & News

$1.05
+0.02 (+1.94 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.03
Now: $1.05
$1.05
50-Day Range
$0.84
MA: $1.01
$1.11
52-Week Range
$0.69
Now: $1.05
$2.22
Volume136,386 shs
Average Volume576,007 shs
Market Capitalization$27.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product candidates include Ovaprene, a non-hormonal monthly contraceptive; and SST-6007, a topical sildenafil cream for female sexual arousal disorder. The company has license and collaboration agreement with Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC to develop and commercialize indications for women related to female sexual dysfunction and/or female reproductive health. The company was incorporated in 2005 and is headquartered in San Diego, California.
Read More
Dare Bioscience logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DARE
CUSIPN/A
Phone858-926-7655

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.12 per share

Profitability

Net Income$-14,260,000.00

Miscellaneous

Employees5
Market Cap$27.98 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive DARE News and Ratings via Email

Sign-up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.

Dare Bioscience (NASDAQ:DARE) Frequently Asked Questions

How has Dare Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Dare Bioscience's stock was trading at $1.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DARE stock has increased by 4.0% and is now trading at $1.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Dare Bioscience?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dare Bioscience in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Dare Bioscience.

When is Dare Bioscience's next earnings date?

Dare Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Dare Bioscience.

How were Dare Bioscience's earnings last quarter?

Dare Bioscience Inc (NASDAQ:DARE) released its quarterly earnings results on Thursday, May, 14th. The biotechnology company reported ($0.18) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.34) by $0.16. View Dare Bioscience's earnings history.

What price target have analysts set for DARE?

3 Wall Street analysts have issued 1-year target prices for Dare Bioscience's shares. Their forecasts range from $3.00 to $7.50. On average, they expect Dare Bioscience's stock price to reach $4.83 in the next year. This suggests a possible upside of 360.3% from the stock's current price. View analysts' price targets for Dare Bioscience.

Has Dare Bioscience been receiving favorable news coverage?

Media coverage about DARE stock has trended extremely negative on Monday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Dare Bioscience earned a news sentiment score of -4.5 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutDare Bioscience.

Who are some of Dare Bioscience's key competitors?

What other stocks do shareholders of Dare Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dare Bioscience investors own include FuelCell Energy (FCEL), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV), Vaxart (VXRT), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and Verastem (VSTM).

Who are Dare Bioscience's key executives?

Dare Bioscience's management team includes the following people:
  • Ms. Sabrina Martucci Johnson, Pres, CEO, Sec. & Director (Age 52)
  • Ms. Lisa Walters-Hoffert, Chief Financial Officer (Age 60)
  • Mr. Mark Walters, VP of Operations (Age 64)
  • Ms. MarDee J. Haring-Layton, VP of Accounting & Fin. (Age 43)
  • Dr. David Friend, Chief Scientific Officer

What is Dare Bioscience's stock symbol?

Dare Bioscience trades on the NASDAQ under the ticker symbol "DARE."

Who are Dare Bioscience's major shareholders?

Dare Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (0.15%). View institutional ownership trends for Dare Bioscience.

Which institutional investors are buying Dare Bioscience stock?

DARE stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG. View insider buying and selling activity for Dare Bioscience.

How do I buy shares of Dare Bioscience?

Shares of DARE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dare Bioscience's stock price today?

One share of DARE stock can currently be purchased for approximately $1.05.

How big of a company is Dare Bioscience?

Dare Bioscience has a market capitalization of $27.98 million. The biotechnology company earns $-14,260,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis. Dare Bioscience employs 5 workers across the globe.

What is Dare Bioscience's official website?

The official website for Dare Bioscience is www.darebioscience.com.

How can I contact Dare Bioscience?

Dare Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at 858-926-7655 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.